doctors in a lab environment
February 29, 2024
Our multiple myeloma story: Collaboration drives progress >
portrait image of Gina Fusaro
January 12, 2024
Bringing new meaning to skin-deep: The potential benefits of treating cancers with subcutaneous immunotherapy >
close up sample under microscope
December 06, 2023
Advancing cell therapy: Shaping our approach today to reach more patients tomorrow >
What's the future of cell therapy at BMS?
November 08, 2023
What's the future of cell therapy at BMS? >
Researching lung cancer treatments to give more patients better outcomes
October 05, 2023
Researching lung cancer treatments to give more patients better outcomes >
Untangling the complexities of cancer
June 15, 2023
Untangling the complexity of cancer: Opportunities to accelerate the next wave of innovation for patients >
Scientists at BMS dig deep into disease biology to truly understand cancer and battle it from multiple angles.
May 04, 2023
Using a multimodal toolbox to advance the next generation of cancer treatment >
Cancer Cells
May 01, 2023
Putting patients first: Transforming clinical lessons into development strategies >
My front row seat to the revolution in immune checkpoint inhibition
April 30, 2023
My front row seat to the revolution in immune checkpoint inhibition >
Dana Walker, MD, MSCE, vice president and Global Program Lead, Genitourinary Cancers, at Bristol Myers Squibb
February 05, 2023
Reflecting on research in genitourinary cancers >
January 24, 2023
The power of dual immunotherapy >
December 12, 2022
Biking the globe for C2C4C >